deltatrials
Active Not Recruiting PHASE1 INTERVENTIONAL 1-arm NCT01655836

High-Dose Rate Brachytherapy and Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer

Phase I Trial of High Dose Rate Brachytherapy Combined With Stereotactic Body Radiation Therapy for Intermediate Risk Prostate Cancer Patients

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Conditions Adenocarcinoma of the Prostate Prostate Cancer Recurrent Prostate Cancer Stage IIA Prostate Cancer Stage IIB Prostate Cancer
Interventions Brachytherapy Quality-of-life assessment Questionnaire administration Stereotactic Body Radiation Therapy
Updated 16 times since 2017 Last updated: Sep 4, 2025 Started: Oct 4, 2012 Primary completion: Jul 27, 2016 Completion: Jan 1, 2040
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Adenocarcinoma of the Prostate and Prostate Cancer, this trial is ongoing. The trial is conducted by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University and has accumulated 16 data snapshots since 2012. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~Nov 2017 · 10 months · monthly snapshot~Nov 2017 – ~Jun 2018 · 7 months · monthly snapshot~Jun 2018 – ~Dec 2018 · 6 months · monthly snapshot~Dec 2018 – ~Oct 2019 · 10 months · monthly snapshot~Oct 2019 – ~Jan 2021 · 15 months · monthly snapshot~Jan 2021 – ~May 2022 · 16 months · monthly snapshot~May 2022 – ~Mar 2023 · 10 months · monthly snapshot~Mar 2023 – ~Nov 2023 · 8 months · monthly snapshot~Nov 2023 – ~May 2024 · 6 months · monthly snapshot~May 2024 – ~Jun 2024 · 31 days · monthly snapshot~Jun 2024 – ~Jul 2024 · 30 days · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Jun 2025 · 9 months · monthly snapshot~Jun 2025 – ~Oct 2025 · 4 months · monthly snapshot~Oct 2025 – ~Feb 2026 · 4 months · monthly snapshot~Feb 2026 – present · 6 months · monthly snapshot

Change History

16 versions recorded

  1. Feb 2026 — Present [monthly]

    Active Not Recruiting PHASE1

  2. Oct 2025 — Feb 2026 [monthly]

    Active Not Recruiting PHASE1

  3. Jun 2025 — Oct 2025 [monthly]

    Active Not Recruiting PHASE1

  4. Sep 2024 — Jun 2025 [monthly]

    Active Not Recruiting PHASE1

  5. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE1

▶ Show 11 earlier versions

  1. Jun 2024 — Jul 2024 [monthly]

    Active Not Recruiting PHASE1

    Phase: NA → PHASE1

  2. May 2024 — Jun 2024 [monthly]

    Active Not Recruiting NA

  3. Nov 2023 — May 2024 [monthly]

    Active Not Recruiting NA

    Phase: PHASE1 → NA

  4. Mar 2023 — Nov 2023 [monthly]

    Active Not Recruiting PHASE1

  5. May 2022 — Mar 2023 [monthly]

    Active Not Recruiting PHASE1

  6. Jan 2021 — May 2022 [monthly]

    Active Not Recruiting PHASE1

  7. Oct 2019 — Jan 2021 [monthly]

    Active Not Recruiting PHASE1

  8. Dec 2018 — Oct 2019 [monthly]

    Active Not Recruiting PHASE1

  9. Jun 2018 — Dec 2018 [monthly]

    Active Not Recruiting PHASE1

  10. Nov 2017 — Jun 2018 [monthly]

    Active Not Recruiting PHASE1

    Status: Recruiting → Active Not Recruiting

  11. Jan 2017 — Nov 2017 [monthly]

    Recruiting PHASE1

    First recorded

Oct 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Data source: Thomas Jefferson University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations